Morgan Stanley Files 8-K with Financial Exhibits

TL;DR

MS filed an 8-K with financial docs, nothing major to see here.

AI Summary

On June 28, 2024, Morgan Stanley filed an 8-K report detailing various financial statements and exhibits. The filing includes information on common stock, preferred stock series (A, E, F, I, K, L, O, P), and medium-term notes. No specific transactions or material events were disclosed beyond the filing of these financial documents.

Why It Matters

This filing provides an update on Morgan Stanley's financial structure and outstanding securities, which is important for investors and regulators to monitor the company's financial health and compliance.

Risk Assessment

Risk Level: low — The filing is routine and primarily consists of financial statements and exhibits without disclosing any new material events or risks.

Key Players & Entities

• MORGAN STANLEY (company) — Filer
• 20240628 (date) — Report Date
• 0000895421 (company) — Central Index Key
• 1585 BROADWAY (address) — Business Address
• NEW YORK (location) — Business City

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value MS New York Stock Exchange
• $0.925 — its quarterly common stock dividend to $0.925 per share from the current $0.85 per sh
• $0.85 — nd to $0.925 per share from the current $0.85 per share, beginning with the common st
• $20 b — quity share repurchase program of up to $20 billion, without a set expiration date, b

Filing Documents

• dp213622_8k.htm (8-K) — 54KB
• dp213622_ex9901.htm (EX-99.1) — 8KB
• image_001.jpg (GRAPHIC) — 3KB
• 0000950103-24-009168.txt ( ) — 332KB
• ms-20240628.xsd (EX-101.SCH) — 5KB
• ms-20240628_def.xml (EX-101.DEF) — 30KB
• ms-20240628_lab.xml (EX-101.LAB) — 41KB
• ms-20240628_pre.xml (EX-101.PRE) — 28KB
• dp213622_8k_htm.xml (XML) — 15KB

01 Other Events

Item 8.01 Other Events. On June 28, 2024, Morgan Stanley (the "Company") announced it will increase its quarterly common stock dividend to $0.925 per share from the current $0.85 per share, beginning with the common stock dividend expected to be declared by the Company's Board of Directors (the "Board") in the quarter ending September 30, 2024 (the "third quarter"). In addition, the Board reauthorized a multi-year common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter. The share repurchases will be exercised from time to time at prices the Company deems appropriate, subject to various considerations, including current market conditions, the Company's capital position and future economic and earnings outlook. On June 26, 2024, the Board of Governors of the Federal Reserve System published summary results of its 2024 supervisory stress tests, as a result of which the Company expects to be subject to a Stress Capital Buffer of 6.0% from October 1, 2024 to September 30, 2025. A copy of the press release relating to this announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K (including the Exhibit hereto) contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they are made, which reflect management's current estimates, projections, expectations, assumptions, interpretations or beliefs of the Company's future results, regulatory capital levels and future capital actions, including common stock dividends and common equity share repurchases, and which are subject to risks and uncertainties that may cause actual results to differ materially. The Company does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of forward-looking statements. For a discussion of additional risks and uncertainties that may affect the future results, regulatory capital levels and future capital actions of the Company, please see "Forward-Looking Statements" preceding Part I, Item 1, "Competition" and "Supervision and Regulation" in Part I, Item 1, "Risk Factors" in Part I, Item 1A, "Legal Proceedings" in Part I, Item 3, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 and "Quantitative and Qualitative Disclosures about Risk" in Part II, Item 7A, in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and other items throughout the Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments thereto.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Morgan Stanley dated June 28, 2024 101 Interactive Data Files pursuant to Rule 406 of Regulation S-T formatted in Inline eXtensible Business Reporting Language ("Inline XBL") 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. MORGAN STANLEY (Registrant) Date: June 28, 2024 By: /s/ Martin M. Cohen Name: Martin M. Cohen Title: Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR